Alkem Laboratories IPO GMP History
Alkem Laboratories IPO has been listed on December 23, 2015 at a listing price of ₹1380, against the issue price of ₹1050 — a gain of ₹330 (+31.43%). The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Alkem Laboratories IPO raised ₹1347.76 Cr. through its IPO at a price band of ₹1020 to ₹1050 per share, with a lot size of 14 shares. The IPO was open for subscription from 08 Dec 2015 to 10 Dec 2015.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 12 Nov, 3:10 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| No GMP history available yet. | |||||
Alkem Laboratories IPO dates
Key dates from opening to listing. Today is 15 November.
- Open 08 Dec 2015
- Close 10 Dec 2015
- Allotment 15 Dec 2015
- Refund/credit TBA
- Listing 23 Dec 2015
Alkem Laboratories IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹1050 |
|---|---|
| Listing gain / loss | +₹330 per share |
| Listing date | 23 Dec, 2015 |
| Actual listing price | ₹1380 (+31.43%) |
Is Alkem Laboratories IPO GMP reliable?
Grey market premium for Alkem Laboratories IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Alkem Laboratories IPO full review for a fundamentals-based assessment before making any grey market trades.
Alkem Laboratories IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Alkem Laboratories IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Alkem Laboratories IPO
Alkem Laboratories Limited is a leading Indian pharmaceutical company. Its promoters include Samprada Singh and Basudeo N. Singh.
It develops, makes and sells pharmaceutical and nutraceutical products, including branded generics, generic drugs, active pharmaceutical ingredients and nutraceuticals.
It markets its products in India and in 55 countries internationally, mainly the United States, through domestic and international businesses.
The IPO was Rs 1,347.76 crore and was entirely an offer for sale at Rs 1,050, the top of the Rs 1,020 to Rs 1,050 band, so the company received no money.
Frequently asked
What is the GMP of Alkem Laboratories IPO?
The current Grey Market Premium (GMP) of Alkem Laboratories IPO is not yet started or active in the market.
What is the Kostak Price of Alkem Laboratories IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Alkem Laboratories IPO is not available.
What is the Subject to Sauda Price of Alkem Laboratories IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Alkem Laboratories IPO?
Alkem Laboratories IPO listed on December 23, 2015 at ₹1380, against the issue price of ₹1050 — a gain of +31.43%.
How did the GMP of Alkem Laboratories IPO trend before listing?
The GMP of Alkem Laboratories IPO was stable in its final days before listing. View the day-wise table above for the complete GMP history.
Explore Alkem Laboratories IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
